A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A. Amarilla, Alexander A. Khromykh, James R. Potter et al.|Nature Communications|2021Cited by 177
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of ConcernMahali S. Morgan, Jody Hobson‐Peters, Kexin Yan et al.|Viruses|2022Cited by 21